Originally used to treat diabetes, semaglutide now provides efficient weight loss. It acts as a GLP-1 hormone mimic, controlling blood sugar levels while promoting weight loss, better blood sugar management, and lowered cardiovascular risk.
Semaglutide decreases cravings and prevents overeating by decreasing appetite, increasing fullness, and delaying stomach emptying. It also lessens the storage of body fat.
Semaglutide increases the production of insulin, inhibits the release of glucose from the liver, and lowers intestinal glucose absorption.
Consequences like nausea, vomiting, and diarrhea can occur. Serious adverse effects
are uncommon.
Sculptra is used to correct shallow to deep wrinkles and folds on the face. Administered with the appropriate injection technique from a trained specialist, Sculptra is clinically approved for:
Sculptra is an injectable biostimulator made of of poly-L-lactic acid (PLLA). Sculptra has a liquid consistency and is injected underneath the skin. Once injected, Sculptra incorporates into the tissues and stimulates your body’s natural production of collagen.
On average, a series of three treatment sessions over the course of a few months may be needed. The number of injections at each session will vary, depending on the degree of correction needed and the treatment plan determined by you and your specialist.
Sculptra is designed to give you noticeable results that emerge gradually and can last up to two years.*Don’t be disappointed if you don’t see immediate results. A few days after treatment, you may look as you did before treatment. This is normal and temporary. The Sculptra regimen delivers its full effects with an average of three treatment sessions over the course of a few months. Because results happen gradually, you’ll see subtle, yet noticeable, results in the reduction of facial wrinkles and folds by comparing images before treatment and a couple months following treatment.†
All rights reserved @ 2023 Harrington Aesthetics